Indeed, in subcutaneous mouse models of tumorigenesis, BLT1‐deficient mice rejected transplanted cancer cells driven by the immunostimulatory cytokine GM‐CSF used as a vaccine and evoked a potent antitumor response to a second challenge with tumor cells. The gene discussed is LTB4R; the disease is cancer.